Remicade “Black Box” Warning On Risk Of Lymphoma Added To Label
This article was originally published in The Pink Sheet Daily
Executive Summary
J&J/Centocor cite six reports of hepatosplenic T-cell lymphoma post-marketing in patients taking concomitant immunosuppressants.
You may also be interested in...
TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.
TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry
The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.
Enbrel “Black Box” Under Consideration By FDA, Amgen Execs Say
Amgen also has received two federal subpoenas related to its products, the firm discloses.